Collplant Biotechnologies Ltd ADR (CLGN) Stock Price, Quote & News

Company Profile

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. The company's products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology. It offers regenerative dermal and soft tissue fillers; 3D-bioprinted regenerative breast implants; VergenixSTR, a soft tissue matri...

Industry: Biotechnology

Sector: Healthcare

Phone: 972 73 232 5600

Fax: 972 73 232 5602

Website: collplant.com

Address:

Weizmann Science Park, 4 Oppenheimer P.O. Box 4132, Rehovot, Israel

mhaven2020 Aug. 22 at 11:18 PM

$TRDA My trade commando scanner takes snapshots and saves them as pdfs. I scan the markwt movers and have an aechive of 3 months of market movers, plus daily scans. My favorite thing to do is compare market movers week to week and then find the best ones. Those sometimes are the alerts, sometimes not. $CLGN $IMRX $CATO

0 · Reply

StockScanners Aug. 22 at 5:49 AM

$CLGN keep watch if this holds above 2.19

0 · Reply

Baba200TradeBot Aug. 21 at 8:00 PM

lowfloatreport.com/ - $CLGN ⬆️ Classic GUSU (Gap Up Stay Up) in action: we opened +6.25% above yesterday’s close at 2.09, powered to 2.56 and are still hovering at 2.49—locking in a +26.6% day and +19.1% from the open—showing bulls defended every dip and shorts never got the fade they needed. 🏋️‍♂️ With only 9.9 M shares floating and just 104 K traded (≈1.0 % float rotation, 0.82 × average volume), supply remains tight; if late-day demand pushes turnover toward the 5-10 % zone, each incremental buy ticket can punch well past the $0.33 ATR, turning a 6 % opening gap into the first leg of a squeeze. 📈 Holding above the gap all session converts that 2.09 level into fresh support, signalling momentum desks that today’s pop isn’t a one-off but a potential launchpad for a continuation run. 🚀 Full data: LowFloatReport.com

0 · Reply

JarvisFlow Aug. 21 at 11:30 AM

HC Wainwright & Co. has adjusted their stance on CollPlant Biotechnologies ( $CLGN ), setting the rating to Buy with a target price of 11.

0 · Reply

LewisDaKat Aug. 21 at 12:25 AM

News COLLPLANT BIOTECHNOLOGIES REPORTS 2025 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE https://marketwirenews.com/news-releases/collplant-biotechnologies-reports-2025-second-quarte-6683607342544851.html $CLGN

0 · Reply

Guraetjje Aug. 20 at 1:38 PM

$CLGN Serious?

0 · Reply

JarvisFlow Aug. 20 at 1:14 PM

D. Boral Capital has updated their rating for CollPlant Biotechnologies ( $CLGN ) to Buy with a price target of 12.

0 · Reply

Guraetjje Aug. 18 at 2:58 PM

$CLGN How do you think the upcoming earnings will turn out?

0 · Reply

StockScanners Aug. 17 at 5:39 AM

$CLGN reached 3.24

0 · Reply

mhaven2020 Aug. 15 at 3:39 PM

$BTBT i closed some of my positions for the week green. Still, have some BTBT but im thin on all my holdings while i do some research on the next ones for next week. Here is the hopper... see any ones you like? $CLGN $RCEL

0 · Reply

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Aug 5, 2025, 7:00 AM EDT - 18 days ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS

Jul 14, 2025, 7:00 AM EDT - 5 weeks ago

CollPlant Appoints Collagen Biomaterials Expert as New Head of North America Commercial Operations

Jun 9, 2025, 7:00 AM EDT - 2 months ago

COLLPLANT BROADENS ITS COLLABORATION WITH STEMCELL TECHNOLOGIES

Jun 4, 2025, 7:00 AM EDT - 2 months ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES EUROPEAN PATENT ALLOWANCE SECURED FOR ITS COLLAGEN-BASED FORMULATIONS USABLE AS SOFT TISSUE FILLERS AND IMPLANTS

May 30, 2025, 7:00 AM EDT - 3 months ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES $3.6 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES

May 28, 2025, 7:00 AM EDT - 3 months ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE

May 14, 2025, 7:00 AM EDT - 3 months ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FIRST QUARTER FINANCIAL RESULTS

Apr 15, 2025, 8:00 AM EDT - 4 months ago

CollPlant's Collink.3D® BioInks and Technologies Offer a Relevant and Timely Solution to FDA's Plan to Reduce Animal Testing in Preclinical Safety Studies

Mar 26, 2025, 7:58 PM EDT - 5 months ago

CollPlant Biotechnologies Ltd. (CLGN) Q4 2024 Earnings Call Transcript

Mar 26, 2025, 8:00 AM EDT - 5 months ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE

SSYS

Mar 19, 2025, 7:00 AM EDT - 5 months ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Feb 24, 2025, 7:00 AM EST - 6 months ago

CollPlant Expands Distribution for its VergenixSTR Product in Europe and Asia

Feb 12, 2025, 6:00 AM EST - 6 months ago

CollPlant Biotechnologies Provides a Corporate Update

Nov 27, 2024, 11:36 AM EST - 9 months ago

CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Transcript

Nov 27, 2024, 7:00 AM EST - 9 months ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

SSYS

Nov 12, 2024, 7:00 AM EST - 10 months ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Aug 20, 2024, 6:59 PM EDT - 1 year ago

CollPlant Biotechnologies Ltd. (CLGN) Q2 2024 Earnings Call Transcript

Aug 20, 2024, 7:00 AM EDT - 1 year ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

SSYS

Aug 19, 2024, 8:30 AM EDT - 1 year ago

CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants

SSYS

Aug 6, 2024, 7:00 AM EDT - 1 year ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 SECOND QUARTER FINANCIAL STATEMENTS AND CONFERENCE CALL INFORMATION

Jul 29, 2024, 7:00 AM EDT - 1 year ago

CollPlant Biotechnologies Unveils Inaugural ESG and Sustainability Report

Jun 6, 2024, 7:00 AM EDT - 1 year ago

CollPlant Successfully Bio-Prints 200cc Commercial-Size Regenerative Breast Implants and Reports Additional Positive Pre-Clinical Data

May 29, 2024, 12:02 PM EDT - 1 year ago

CollPlant Biotechnologies Ltd. (CLGN) Q1 2024 Earnings Call Transcript

May 29, 2024, 7:00 AM EDT - 1 year ago

CollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate Update

May 16, 2024, 7:00 AM EDT - 1 year ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Apr 4, 2024, 1:15 PM EDT - 1 year ago

CollPlant Biotechnologies Ltd. (CLGN) Q4 2023 Earnings Call Transcript

Apr 4, 2024, 7:17 AM EDT - 1 year ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Mar 26, 2024, 8:00 AM EDT - 1 year ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Feb 15, 2024, 8:00 AM EST - 1 year ago

CollPlant Issues Letter to Shareholders

Jan 8, 2024, 7:18 AM EST - 1 year ago

CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California

Jan 2, 2024, 7:00 AM EST - 1 year ago

CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants

Nov 29, 2023, 2:21 PM EST - 1 year ago

CollPlant Biotechnologies Ltd. (CLGN) Q3 2023 Earnings Call Transcript

Nov 29, 2023, 7:00 AM EST - 1 year ago

CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023

Nov 9, 2023, 8:00 AM EST - 1 year ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Nov 1, 2023, 7:05 AM EDT - 1 year ago

CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler

Sep 21, 2023, 7:00 AM EDT - 2 years ago

CollPlant Biotechnologies Joins the United Nations Global Compact, The World's Largest Corporate Sustainability Initiative

Sep 5, 2023, 7:00 AM EDT - 2 years ago

CollPlant to Present at the H.C. Wainwright Annual Growth Conference

Aug 24, 2023, 11:27 PM EDT - 2 years ago

CollPlant Biotechnologies Ltd. (CLGN) Q2 2023 Earnings Call Transcript

Aug 24, 2023, 7:00 AM EDT - 2 years ago

CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million

Aug 9, 2023, 9:02 AM EDT - 2 years ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 SECOND QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Aug 9, 2023, 8:00 AM EDT - 2 years ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2022 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Jun 26, 2023, 7:00 AM EDT - 2 years ago

CollPlant Achieves Milestone and To Receive $10 Million From AbbVie in Accordance with its Regenerative Dermal Filler Product Collaboration Agreement

May 24, 2023, 12:49 PM EDT - 2 years ago

CollPlant Biotechnologies Ltd. (CLGN) Q1 2023 Earnings Call Transcript

May 24, 2023, 7:00 AM EDT - 2 years ago

CollPlant Biotechnologies Announces First Quarter Financial Results For 2023 and Provides Corporate Update

May 2, 2023, 9:00 AM EDT - 2 years ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Apr 4, 2023, 8:26 AM EDT - 2 years ago

Stratasys and CollPlant Unite Technologies to Transform Healthcare with Industrial-Scale Bioprinting of Tissues and Organs

SSYS

Mar 29, 2023, 12:28 PM EDT - 2 years ago

CollPlant Biotechnologies Ltd. (CLGN) Q4 2022 Earnings Call Transcript

Mar 29, 2023, 7:00 AM EDT - 2 years ago

Collplant Biotechnologies Announces Full-Year Financial Results For 2022 and Provides Corporate Update

Mar 14, 2023, 7:00 AM EDT - 2 years ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2022 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

mhaven2020 Aug. 22 at 11:18 PM

0 · Reply

StockScanners Aug. 22 at 5:49 AM

$CLGN keep watch if this holds above 2.19

0 · Reply

Baba200TradeBot Aug. 21 at 8:00 PM

0 · Reply

JarvisFlow Aug. 21 at 11:30 AM

HC Wainwright & Co. has adjusted their stance on CollPlant Biotechnologies ( $CLGN ), setting the rating to Buy with a target price of 11.

0 · Reply

LewisDaKat Aug. 21 at 12:25 AM

0 · Reply

Guraetjje Aug. 20 at 1:38 PM

$CLGN Serious?

0 · Reply

JarvisFlow Aug. 20 at 1:14 PM

D. Boral Capital has updated their rating for CollPlant Biotechnologies ( $CLGN ) to Buy with a price target of 12.

0 · Reply

Guraetjje Aug. 18 at 2:58 PM

$CLGN How do you think the upcoming earnings will turn out?

0 · Reply

StockScanners Aug. 17 at 5:39 AM

$CLGN reached 3.24

0 · Reply

mhaven2020 Aug. 15 at 3:39 PM

0 · Reply

mhaven2020 Aug. 13 at 8:29 PM

$VTYX $BTBT $MDAI $RCEL $CLGN Thanks to all those who subscribe! You all make it worth it! I'm dropping some videos soon! Sign up for trade alerts on our website!

2 · Reply

dln101 Aug. 12 at 1:51 PM

$CLGN next stop $4 🤔💪📈

0 · Reply

StockScanners Aug. 9 at 11:58 PM

$CLGN reached 2.97

0 · Reply

mhaven2020 Aug. 8 at 4:14 PM

$CLGN picked up a little mlre alpng with $ONDS and $ASPN. Holding until wednesday, probably. If you want 4 solid tickers sent to your email daily, sign up for trade commando alerts on our website for $2.99 a month. The stock sniper program is available there as well. Have a great weekend! http://easypcs.us/catalog.html.

0 · Reply

mhaven2020 Aug. 8 at 12:32 PM

$CLGN is looking good. I'm in along with these other ones and $LPSN

0 · Reply

dln101 Aug. 7 at 12:43 PM

$CLGN do we clear 3 or 4 today? 🤔

0 · Reply

StockScanners Aug. 7 at 1:12 AM

$CLGN Keep watch if this holds above 2.50

0 · Reply

dln101 Aug. 6 at 8:26 PM

$CHEK this low float bio seems at support, time to join peer $CLGN give some spikes all over again $CREG style 🤔💪🔥🚀

1 · Reply

baa75 Aug. 6 at 7:05 PM

$CLGN 🧐

0 · Reply

kshonstocks Aug. 6 at 6:25 PM

$CLGN EPS % Chg (Last Qtr) 71% EPS Est % Chg (Current Yr) 81% Sales % Chg (Last Qtr) 1960% 3-Year Sales Growth Rate 31% https://research.investors.com/stock-quotes/nasdaq-collplant-biotech-clgn.htm one to eye

0 · Reply

dln101 Aug. 5 at 3:14 PM

$CLGN maybe next $YMAB this low float bio likes to spike put of nowhere 🤔💪🔥🚀

0 · Reply

RedDogSailor Aug. 1 at 2:24 PM

$CLGN Steady as she goes. Next leg up coming

0 · Reply

Market Cap	30.52M
Revenue (ttm)	520,000.00
Net Income (ttm)	-16.61M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-3,194.23%
Debt to Equity Ratio	0.00

Volume	44,400
Avg Vol	73,250
Day's Range	N/A - N/A
Shares Out	12.72M
Stochastic %K	48%
Beta	1.47
Analysts	Strong Sell
Price Target	$11.50